Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @
Roche Stops Work on Obesity Drug Emugrobart After Trial Data
RRoche

Roche Stops Work on Obesity Drug Emugrobart After Trial Data

  • 2026-11-02

Roche Holding ROP -0.31%decrease; down pointing triangle said it stopped work on one of its obesity-drug candidates, after clinical-trial data suggested the medicine wouldn’t hit internal targets.

The Swiss drugmaker said it returned rights to the medicine, emugrobart, to its majority-owned business Chugai Pharmaceutical 4519 2.74%increase; up pointing triangle, which originally discovered the drug and licensed it to Roche.

Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

  • Tags:
  • 4519.TO
  • business
  • Business/Consumer Services
  • C&E Industry News Filter
  • CH:ROP
  • Chugai Pharmaceutical
  • community
  • consumer services
  • Content Types
  • corporate
  • Corporate/Industrial News
  • development
  • Diagnostic
  • Diagnostic/Medical Research Services
  • Dragonfly - Europe
  • Dragonfly - World
  • Europe
  • Factiva Filters
  • GCAPI
  • General news
  • Health
  • Health/Medicine
  • Healthcare
  • Healthcare Support Services
  • Healthcare/Life Sciences
  • industrial news
  • JP:4519
  • life sciences
  • LINK:EN|drn:realtime.linkedarticle.DNCO20260929000792
  • Manufacturing
  • Medical Research Services
  • medicine
  • new product
  • New Product/Service Testing
  • new products
  • New Products/Services
  • newsplus
  • Obesity
  • Pharmaceuticals
  • political
  • Political/General News
  • products
  • Products/Services
  • research
  • Research/Development
  • Roche
  • Roche Holding
  • ROP.EB
  • Scientific Research Services
  • service testing
  • Services
  • Social issues
  • Society
  • Society/Community
  • Switzerland
  • SYND
  • Western Europe
  • WSJ-PRO-WSJ.com
Switzerland
www.europesays.com